Back to Search
ASHLEY LY, PHARMD
PHARMD
Pharmacist
NPI: 1912480872Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.
PMID 11477137·Mol Pathol·2001
8-other
PROP (6-n-Propylthiouracil) tasting and sensory responses to caffeine,sucrose, neohesperidin dihydrochalcone and chocolate.
PMID 11124214·Chem Senses·2001
8-other
Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.
PMID 11191646·Life Sci·2000
7-preclinical
Expression of insulin-like growth factor-I in rat glioma cells is associated with change in both immunogenicity and apoptosis.
PMID 10686404·Neurosci Lett·2000
7-preclinical
Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening.
PMID 19580414·Clin Infect Dis·2009
4-observational
Assessment of the relative success of sporozoite inoculations in individuals exposed to moderate seasonal transmission.
PMID 19604389·Malar J·2009
7-preclinical
Modulation of long-term memory for object recognition via HDAC inhibition.
PMID 19470462·Proc Natl Acad Sci U S A·2009
7-preclinical
A pharmacy practice residency (PGY1) with an emphasis on academia.
PMID 19513151·Am J Pharm Educ·2009
8-other
DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1.
PMID 18585357·Cell·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4908 HOUSTON FIELD CT
CHARLOTTE, NC 28277 - Phone
- (704) 814-0212
Quick Facts
- NPI
- 1912480872
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile